ARCHIVES

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

This article is from The Cancer Letter archive.

Vol. 14 No. 37 | September 23, 1988

Download PDF Visit The Full Archive

Related Articles

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013

Cooperative Group Reorganization To Be Offered By DeVita At Clinical Trials Review Next March

October 20, 1978

NIH Human Connectome Project To Map Brain Connections

July 31, 2009

In Brief: ONS, ASCO AACR Meetings Open In St. Louis Next Week; Bristol-Myers Adds Farber, McArdle Grants

April 16, 1982